Istituto per la Ricerca e l'Innovazione Biomedica Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2014
NCT02409563
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Istituto per la Ricerca e l'Innovazione Biomedica | Stefania La Grutta, MD